Article
Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.
Bone - 1 Mar 2015
Gasque Kellen C S, Foster Brian L, Kuss Pia, Yadav Manisha C, Liu Jin, Kiffer-Moreira Tina, van Elsas Andrea, Hatch Nan, Somerman Martha J, Millán José Luis
Abstract excerpt
Hypophosphatasia (HPP) results from ALPL gene mutations, which lead to a deficiency of tissue-nonspecific alkaline phosphatase (TNAP), and accumulation of inorganic pyrophosphate, a potent inhibitor of mineralization that is also a natural substrate of TNAP, in the extracellular space. HPP causes mineralization disorders including soft bones (rickets or osteomalacia) and defects in teeth and periodontal tissues....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
